|
Name |
1-Pentadecene
|
Molecular Formula | C15H30 | |
IUPAC Name* |
pentadec-1-ene
|
|
SMILES |
CCCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C15H30/c1-3-5-7-9-11-13-15-14-12-10-8-6-4-2/h3H,1,4-15H2,2H3
|
|
InChIKey |
PJLHTVIBELQURV-UHFFFAOYSA-N
|
|
Synonyms |
1-PENTADECENE; 13360-61-7; Pentadec-1-ene; Pentadecene; PENTADECENE,1-; KH577LIA74; NSC-77125; 27251-68-9; CCRIS 5721; EINECS 236-414-5; NSC 77125; UNII-KH577LIA74; MFCD00008987; 1-Pentadecene, 98%; UNII-2M9QW46A8B; 2M9QW46A8B; DTXSID1065421; CHEBI:77506; NSC77125; ZINC1708386; EINECS 248-364-1; LMFA11000327; AKOS015912787; AS-56500; DB-042190; CS-0186359; FT-0608197; P0627; S0345; D83561; J-006413; Q3374882; 7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE,1,4-DIHYDRO-
|
|
CAS | 13360-61-7 | |
PubChem CID | 25913 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 210.4 | ALogp: | 8.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 15 | QED Weighted: | 0.275 |
Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00001270 |
Pgp-inhibitor: | 0.011 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.249 |
30% Bioavailability (F30%): | 0.787 |
Blood-Brain-Barrier Penetration (BBB): | 0.514 | Plasma Protein Binding (PPB): | 99.61% |
Volume Distribution (VD): | 2.364 | Fu: | 1.37% |
CYP1A2-inhibitor: | 0.584 | CYP1A2-substrate: | 0.204 |
CYP2C19-inhibitor: | 0.5 | CYP2C19-substrate: | 0.09 |
CYP2C9-inhibitor: | 0.19 | CYP2C9-substrate: | 0.933 |
CYP2D6-inhibitor: | 0.267 | CYP2D6-substrate: | 0.34 |
CYP3A4-inhibitor: | 0.523 | CYP3A4-substrate: | 0.074 |
Clearance (CL): | 4.462 | Half-life (T1/2): | 0.097 |
hERG Blockers: | 0.104 | Human Hepatotoxicity (H-HT): | 0.01 |
Drug-inuced Liver Injury (DILI): | 0.045 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.031 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.961 | Carcinogencity: | 0.071 |
Eye Corrosion: | 0.994 | Eye Irritation: | 0.969 |
Respiratory Toxicity: | 0.336 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000425 | 0.935 | D0Z5SM | 0.565 | ||||
ENC000475 | 0.930 | D05ATI | 0.552 | ||||
ENC000557 | 0.878 | D07ILQ | 0.515 | ||||
ENC000510 | 0.860 | D0O1PH | 0.493 | ||||
ENC000283 | 0.827 | D0Z5BC | 0.491 | ||||
ENC000607 | 0.792 | D00AOJ | 0.467 | ||||
ENC000273 | 0.791 | D00FGR | 0.422 | ||||
ENC000589 | 0.782 | D05QNO | 0.379 | ||||
ENC000422 | 0.729 | D0P1RL | 0.373 | ||||
ENC001240 | 0.729 | D0O1TC | 0.359 |